TORONTO, ON / ACCESSWIRE / February 8, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced it ...

Toronto, Ontario -January 29, 2013 -- Theralase Technologies Inc. (TSX-V:TLT.V - News) is pleased to announce that effective January 15, 2013, Michael Jewett MD, FRCSC, FACS has elected to join its ...

Dr. Stephen R. Jewett, 85, died at his home in New Bern, NC, on October 7, 2008. Formerly of Clarks Summit, Pennsylvania, Dr. Jewett graduated from Clarks Summit High School in 1940. He earned his ...

Dr. Theodore C. Jewett Jr., a fourth-generation Western New Yorker and longtime chief of pediatric surgery at Children's Hospital, died Friday in his Williamsville home after a long illness. He was 85 ...

Dr. Richard Pazdur, who has been the F.D.A.’s top cancer drug regulator, represents a stabilizing choice for an agency ...